ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS

Size: px
Start display at page:

Download "ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS"

Transcription

1 ROLE OF HEALTH CARE PROVIDERS IN THE MANAGEMENT OF ALCOHOL AND DRUG USE RELATED PROBLEMS Dr. Anita Rao? ASK SCREEN Refer HELP T T Ranganathan Clinical Research Foundation TTK Hospital IV Main Road, Indira Nagar, Chennai , India. Phone: / / Fax: ttkhospital@gmail.com, Website: June

2 Alcohol and drug use can impact health, work performance as well as family and social relationships. Yet, unlike other diseases, people may not be able to recognize the problems caused due to hazardous alcohol / drug use. Health care providers can help to: - Identify alcohol and drug use problems in the early stage and assess level of risk - Intervene by providing medical support and advise - Refer patients for specialized addiction treatment services if required. I. EARLY IDENTIFICATION THROUGH ROUTINE SCREENING ASK? As a routine, ask all patients if they drink alcohol or use other drugs without a physician's prescription. Some may report using more than the recommended dosage of prescription drugs (sleep inducing drugs such as diazepam or pain killers such as propoxyphene). Few may use illicit drugs such as heroin (brown sugar) or cannabis (ganja). Explain that even occasional use of small amount of alcohol and drugs can lead to accidents, falls, violence etc. Harmful level of alcohol/ drug use can lead to general deterioration of the body by reducing appetite, altering sleep patterns etc., It can also lead to : - Liver disorders such as fatty liver, alcoholic hepatitis, cirrhosis etc., - Gastro intestinal disorders (gastritis, ulcers, esophageal varices, pancreatitis etc.) - Neurological problems (neuropathy, dementia, etc). - Regular use can also increase the risk of dependence or addiction. - Use of drugs like cannabis can trigger a psychiatric break down. - Sharing of injecting equipments can lead to HIV, hepatitis B or C or other blood borne infections.

3 If no use is reported, we can say, We are happy that you do not use alcohol or other drugs. You have made a smart decision. If use is reported, enquire about the quantity and frequency of use. (Please note: 30 ml of distilled spirit such as brandy/whisky/vodka equals one unit of alcohol and 650 ml of beer can be treated as 2 units of alcohol). If patient uses not more than 3 units of alcohol in a day and not more than 7 units a week, message of caution can be given by saying : As of now you are not drinking heavily but make sure you do not increase the quantity or frequency of use. Remember that even small amounts of alcohol can cause accidents especially while driving or operating machinery. If patient reports occasional use of drugs (illicit drugs or prescription drugs without advice of physician), state : Drug use can quickly develop into addiction. It would be best for you to stop using it If patient uses alcohol more than 3 units a day or more than 7 units a week and / or regular use of drugs with or without associated problems : - With alcohol users administering a screening test such as AUDIT can help. SCREEN - If patient uses other drugs, provide information about health problems associated with that particular drug. - Assess for addiction. If the patient experiences craving to use, finds it difficult to restrict quantity / frequency of use or continues to use alcohol or drugs in spite of negative consequences, addiction may have developed. It is important to assess level of Substance Use Disorder based on criteria listed in DSM 5.

4 WHAT NEEDS TO BE DONE? Patient is NOT substance dependent Explain the consequences of continuing with present pattern of alcohol/drug use. Help patient develop a plan to reduce or stop use (avoid drinking places, handle stress, boredom or other problems without resorting to use of alcohol/drugs, saying No to offer of alcohol/drugs etc). Ask patient to maintain record of alcohol/drugs used and provide guidance based on its record during followup visits. Patient could be substance dependent Explain consequences of continuing with present pattern of alcohol/drug use. Provide medical help to deal with withdrawal symptoms if needed Refer patient for specialized addiction treatment services. Suggest attending AA/NA self help group meetings ( A l c o h o l i c / N a r c o t i c s Anonymous). II. Medical management of withdrawal symptoms : HELP The nature and severity of withdrawal symptoms depends largely on the type and quantity of alcohol/drug used and health condition. Most patients require vitamin supplements while alcohol users often require antacids, liver supplements and large doses of thiamine to prevent onset of Wernicke's disease. Those with history of withdrawal fits need anti-convulsants. Injectable diazepam or lorazepam can be used in case of agitation. As psychiatric comorbidity is common among addicted patients, anti depressants, anti psychotics and mood stabilizers may be required. The most commonly noted withdrawal symptoms and its management are listed below.

5 Type of substance Withdrawal symptoms Medications suggested - Alcohol - Benzodiazepines (diazepam, alprazolam) Cannabis (Ganja, hashish, bhang) Tremors, insomnia, anxiety, seizures, h a l l u c i n a t i o n s, delirium. Insomnia, restlessness, sweating, loss of appetite. D e p r e s s i o n o r psychotic symptoms may become prominent. - Chlordiazepoxide 50 to 200 mg in divided doses depending on severity for 3 to 5 days and tapered off in 7 days. - A n t i - c o n v u l s a n t s i f required. - Delirium can be life threatening and is best managed in a setting equipped to deal with medical emergencies. - S y m p t o m s a r e n o n s p e c i f i c a n d Chlordiazepoxide may be used for 3 to 5 days and tapered later. Opioids (heroin/brown sugar, pentazocine, propoxyphene) B o d y p a i n, r e s t l e s s n e s s, diarrhoea, vomiting, body chills alternating with sweating, watery discharge from eyes and nose. - Clonidine (0.3 to 0.6 mg) for 3 to 5 days and tapered off in 7 days. - Chlordiazepoxide may be used for sleep and stopped in 7 days. III. Medical management of withdrawal symptoms: Refer Providing medical assistance to manage withdrawal symptoms in a safe and comfortable manner (detoxification) alone cannot be considered as treatment for addiction. Addiction is a brain disease and patients require help to give up use of alcohol/drugs completely and make qualitative lifestyle changes to support the decision to remain drug free.

6 Addiction treatment should comprise of four core components and TTK Hospital offers an one month programme that encompasses all of these. a) Medical assistance to handle physical and mental health problems caused by or made worse by substance use and pharmacotherapy (disulfiram, naltrexone etc) to support abstinence. b) Psychological therapy wherein information is provided about addiction and recovery as well as group therapy and counseling sessions to establish abstinence from mood changing substances and improve quality of life. c) Family therapy to assist family members in their own recovery and provide appropriate support to patient. d) Follow-up services to sustain recovery. Addiction is a treatable disease. By presenting facts, expressing optimism about their ability to make changes and providing some help, health care providers can : - Act as prevention agents and dissuade people from using alcohol/drugs - Intervene to reduce harmful use of alcohol/drugs - Carry out referrals for addiction treatment in the early stages increasing the prognosis of recovery. TTRCRF (TTK Hospital) started in 1980 is a premier non profit professionally managed 100 bed addiction treatment centre. It runs a residential one month primary care programme and a two month extended care treatment programme. Community based treatment camps are conducted for the rural poor in Tamil Nadu. TTK is also involved in awareness building, work place prevention, training and publications related to addiction.

ALCOHOLISM A TREATABLE DISEASE

ALCOHOLISM A TREATABLE DISEASE ALCOHOLISM A TREATABLE DISEASE T T Ranganathan Clinical Research Foundation TTK Hospital IV Main Road Indira Nagar Chennai 600 020 India Phone: 2491 2948 / 2491 8461 / 2491 2949 Email: ttrcrf@gmail.com,

More information

Dealing with Alcohol and Drug use

Dealing with Alcohol and Drug use Dealing with Alcohol and Drug use Role of Social Workers / Psychologists Role clarity Helpful Listening well Commitment Patience T T Ranganthan Clinical Research Foundation TTK Hospital, IV Main Road,

More information

Drug & Alcohol Detox:

Drug & Alcohol Detox: Drug & Alcohol Detox: Beginning Stages of Addiction Treatment If you ve tried to detox on your own and failed, you are not alone. The good news is that research shows those who commit to a rehabilitation

More information

Buprenorphine & Controlled Substance Treatment Agreement

Buprenorphine & Controlled Substance Treatment Agreement Buprenorphine & Controlled Substance Treatment Agreement I agree to accept the following treatment contract for buprenorphine office-based opioid addiction treatment: 1. I will keep my medication in a

More information

Session 2: Alcohol and Recovery 2-1

Session 2: Alcohol and Recovery 2-1 Session 2: Alcohol and Recovery 2-1 Alcohol in the Brain Alcohol upsets a delicate balance between chemical systems that stimulate and chemical systems that inhibit functions of the brain and body. Matrix

More information

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph

UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph UNDERSTANDING THE DISEASE OF ADDICTION by Suresh Joseph Summary of Presentation Addiction as a disease Medical harm of substance use Treatment models for substance dependence Local support services for

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR ALCOHOL DEPENDENCE INDICATION Naltrexone is used as part of a comprehensive programme of treatment against alcoholism to reduce the

More information

Substance Misuse in Older People

Substance Misuse in Older People Substance Misuse in Older People Dr Tony Rao Consultant Old Age Psychiatrist, SLAM NHS Foundation Trust Visiting Researcher, Institute of Psychiatry, Neurology and Neuroscience Chair of Substance Misuse

More information

Controlled Substance and Wellness Agreement

Controlled Substance and Wellness Agreement Controlled Substance and Wellness Agreement You and your provider have agreed on the use of controlled substance medications to treat your: We want to make sure you know how to manage your new prescription(s)

More information

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center

Medical Assisted Treatment. Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Medical Assisted Treatment Dr. Michael Baldinger Medical Director Haymarket Center Harborview Recovery Center Current Trends Prescription Drug Abuse/Addiction Non-medical use of prescription pain killers

More information

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration

What is pregabalin? Pregabalin tablets. Pregabalin misuse. National Drug Treatment Centre Research. Administration What is pregabalin? Pregabalin is a prescription drug used to manage a number of long-term conditions, including epilepsy, neuropathic pain and generalised anxiety disorder. Similar to benzodiazepines,

More information

Screening Patients for Substance Use in Your Practice Setting

Screening Patients for Substance Use in Your Practice Setting Screening Patients for Substance Use in Your Practice Setting Learning Objectives By the end of this session, participants will Understand the rationale for universal screening. Identify potential health

More information

Alcoholism. Social environment, stress, mental health, family history, age, ethnic group, and gender all influence the risk for the condition.

Alcoholism. Social environment, stress, mental health, family history, age, ethnic group, and gender all influence the risk for the condition. SAY NO TO ALCOHOL Alcoholism Alcoholism is a chronic and often progressive disease that includes problems controlling your drinking, being preoccupied with alcohol, continuing to use alcohol even when

More information

Opioid dependence: Detoxification

Opioid dependence: Detoxification Opioid dependence: Detoxification What is detoxification? A. Process of removal of toxins from the body? B. Admitting a drug dependent person in a hospital and giving him nutrition? C. Stopping drug use

More information

A Guide to Alcoholism and Problem Drinking

A Guide to Alcoholism and Problem Drinking A Guide to Alcoholism and Problem Drinking Alcoholism is a word which many people use to mean alcohol dependence (alcohol addiction). Some people are problem drinkers without being dependent on alcohol.

More information

Alcohol-Related Liver Disease

Alcohol-Related Liver Disease Alcohol-Related Liver Disease Nonalcoholic Fatty Liver Disease (NAFLD) 1 Why is the liver important? Your liver is a vital organ that performs many essential functions. It filters out harmful substances

More information

Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust

Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Guidelines for the In-Patient Management of Alcohol Withdrawal at Frimley Park Hospital NHS Foundation Trust Authors: Dr Aftab Ala, Consultant Gastroenterologist & Hepatologist Dr Tasneem Pirani, ST4 in

More information

TADPole: Treating Alcohol & other Drugs in Primary Care

TADPole: Treating Alcohol & other Drugs in Primary Care Assessment The following are issues to consider in assessment. Drug use and treatment Quantity and pattern of use of all licit and illicit drugs Previous treatment and complications Dependence (tolerance,

More information

Management of Alcohol Dependence

Management of Alcohol Dependence STANDARD TREATMENT GUIDELINES Management of Alcohol Dependence Quick Reference Guide February 2016 Ministry of Health & Family Welfare Government of India 1 Table of Contents Objectives-... 3 Diagnosis...

More information

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics.

DISCLAIMER: ECHO Nevada emphasizes patient privacy and asks participants to not share ANY Protected Health Information during ECHO clinics. DISCLAIMER: Video will be taken at this clinic and potentially used in Project ECHO promotional materials. By attending this clinic, you consent to have your photo taken and allow Project ECHO to use this

More information

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine

Opioid Agonists. Natural derivatives of opium poppy - Opium - Morphine - Codeine Natural derivatives of opium poppy - Opium - Morphine - Codeine Opioid Agonists Semi synthetics: Derived from chemicals in opium -Diacetylmorphine Heroin - Hydromorphone Synthetics - Oxycodone Propoxyphene

More information

Alcohol - an issue for older women too! Rolande Anderson-Project Director ICGP Helping Patients with Alcohol Problems

Alcohol - an issue for older women too! Rolande Anderson-Project Director ICGP Helping Patients with Alcohol Problems Alcohol - an issue for older women too! Rolande Anderson-Project Director ICGP Helping Patients with Alcohol Problems Main points Is any alcohol beneficial? Hidden problem; They don t run down the streets

More information

Prescription Opioid Addiction

Prescription Opioid Addiction CSAM-SCAM Fundamentals Prescription Opioid Addiction Presentation provided by Meldon Kahan, MD Family & Community Medicine University of Toronto Conflict of interest statement I received funds from Rickett

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2009 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

How does cannabis affect my work performance?

How does cannabis affect my work performance? How does cannabis affect my work performance? How does cannabis affect my work performance? Driving skills and ability to operate machinery Using cannabis negatively affects your balance, coordination,

More information

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS

TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Fact Sheet N 127 August 1996 TRENDS IN SUBSTANCE USE AND ASSOCIATED HEALTH PROBLEMS Psychoactive substance use is an increasing public health concern. Problems associated with this use cover a broad spectrum

More information

What I Want From Treatment User Information

What I Want From Treatment User Information What I Want From Treatment User Information The tailoring to treatment to individual needs has long been lauded, but often it is designing treatment to what the counselor thinks the client needs. This

More information

AACN PCCN Review. Behavioral

AACN PCCN Review. Behavioral AACN PCCN Review Behavioral Presenter: Carol A. Rauen, RN, MS, CCNS, CCRN, PCCN, CEN Independent Clinical Nurse Specialist & Education Consultant rauen.carol104@gmail.com 0 Behavioral I. INTRODUCTION PCCN

More information

Alcoholism And Addiction In The Elderly

Alcoholism And Addiction In The Elderly Alcoholism And Addiction In The Elderly 1) The National Institute on Drug Abuse states that addiction is defined as a chronic, relapsing disease. a) Brain b) Moral c) Physical d) Impulse Control 2) Approximately

More information

Overview of Psychoactive Drug use

Overview of Psychoactive Drug use Overview of Psychoactive Drug use By Dr. Oladosu Ahmed Kayode Specialist in mental health Attending physician Dept. of psychiatry, GH Ilorin & Hopeville Psychiatric Hospital, Ilorin. Learning objectives

More information

Drugs in American Society CHD 601. Legal Drugs Alcohol

Drugs in American Society CHD 601. Legal Drugs Alcohol Drugs in American Society CHD 601 Legal Drugs Alcohol Unit 2 Last updated April 12, 2017 Edward Pierce, LCSW Overview From the last class Counseling videos Quiz 1 Process Other items Alcohol Biochemical

More information

Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical)

Admit date: 1-WM 2-WM 3.2-WM 3.7-WM 4-WM DSM-V diagnoses: Please list all diagnoses (psychiatric, chemical dependency and medical) https://providers.amerigroup.com Substance Use Disorder Withdrawal Management Prior Authorization and Continued Care Request (Use for American Society of Addiction Medicine [ASAM] withdrawal management

More information

Top of the World Ranch Treatment Centre Admissions Information Record Demographics

Top of the World Ranch Treatment Centre Admissions Information Record Demographics 1 Client Name: Date of Birth: Top of the World Ranch Treatment Centre Admissions Information Record Demographics Alias or AKA : Date: Gender: Male Female Phone #: May we leave a message? Street Address:

More information

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Basics of Benzodiazepine Use Disorder DATE: June 12, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members

More information

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines

The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines The available evidence in the field of treatment of opiate: The experience of developing the WHO clinical guidelines Background, Objectives and Methods Systematic reviews (SRs) published by Cochrane Drugs

More information

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They?

Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Medications in the Treatment of Opioid Use Disorder: Methadone and Buprenorphine What Really Are They? Yngvild Olsen, MD, MPH Cecil County Board of Health Workgroup Meeting Elkton, MD October 8, 2013 Objectives

More information

Substance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder

Substance and Alcohol Related Disorders. Substance use Disorder Alcoholism Gambling Disorder Substance and Alcohol Related Disorders Substance use Disorder Alcoholism Gambling Disorder What is a Substance Use Disorder? According to the DSM-5, a substance use disorder describes a problematic pattern

More information

Taking an alcohol history

Taking an alcohol history Taking an alcohol history Dr Tony Rao Consultant Old Age Psychiatrist, SLAM NHS Foundation Trust Visiting Researcher, Institute of Psychiatry, Neurology and Neuroscience Alcohol related brain damage Alcohol

More information

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging.

Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. David W. Oslin, MD University of Pennsylvania Philadelphia VAMC Dr. Oslin receives grant support from the NIH, VA, and the Pennsylvania Department of Aging. Dr. Oslin is a consultant to the Hazelden Betty

More information

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014

NORTHWEST AIDS EDUCATION AND TRAINING CENTER. Opioid Use Disorders. Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 NORTHWEST AIDS EDUCATION AND TRAINING CENTER Opioid Use Disorders Joseph Merrill M.D., M.P.H. University of Washington April 10, 2014 Opioid Use Disorders Importance of opioid use disorders Screening and

More information

1/10/2017. A common Alcoholics Anonymous (AA) saying is There is no problem that alcohol cannot make worse.

1/10/2017. A common Alcoholics Anonymous (AA) saying is There is no problem that alcohol cannot make worse. Alcohol still addicts more people than all other drugs combined Understand difference between alcohol use, abuse and dependence Learn the potential physiological and emotional affects of alcohol Distinguish

More information

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Basics of Benzodiazepine Use Disorder DATE: March 20, 2018 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker: Melissa Weimer, DO, MCR, has nothing to disclose. Planning Committee: The members

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2008 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD)

Guidelines MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) MANAGEMENT OF MAJOR DEPRESSIVE DISORDER (MDD) Guidelines CH Lim, B Baizury, on behalf of Development Group Clinical Practice Guidelines Management of Major Depressive Disorder A. Introduction Major depressive

More information

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION

SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION SUBOXONE (buprenorphine and naloxone) sublingual film (CIII) IMPORTANT SAFETY INFORMATION What is the most important information I should know about SUBOXONE Film? Keep SUBOXONE Film in a secure place

More information

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR

Basics of Benzodiazepine Use Disorder. DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR Basics of Benzodiazepine Use Disorder DATE: October 3, 2017 PRESENTED BY: Melissa B. Weimer, DO, MCR Disclosures Speaker disclosure: One time lecture sponsored by Indivior about overlap of pain and opioid

More information

Module II Opioids 101 Opiate Opioid

Module II Opioids 101 Opiate Opioid BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module II Opioids 101 Module II Goals of the Module This module reviews the following:! Opioid addiction and the brain!

More information

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders

Main Questions. Why study addiction? Substance Use Disorders, Part 1 Alecia Schweinsburg, MA Abnromal Psychology, Fall Substance Use Disorders Substance Use Disorders Main Questions Why study addiction? What is addiction? Why do people become addicted? What do alcohol and drugs do? How do we treat substance use disorders? Why study addiction?

More information

Alcohol Interventions: NICE guidelines and beyond. Professor Colin Drummond

Alcohol Interventions: NICE guidelines and beyond. Professor Colin Drummond Alcohol Interventions: NICE guidelines and beyond Professor Colin Drummond What this presentation covers Background Scope Methodology What is new? Implications for practice Implementation International

More information

*IN10 BIOPSYCHOSOCIAL ASSESSMENT*

*IN10 BIOPSYCHOSOCIAL ASSESSMENT* BIOPSYCHOSOCIAL ASSESSMENT 224-008B page 1 of 5 / 06-14 Please complete this questionnaire and give it to your counselor on your first visit. This information will help your clinician gain an understanding

More information

SCREENING FOR COMMON MENTAL DISORDERS DEPRESSIVE AND ANXIETY DISORDERS SUBSTANCE USE DISORDERS

SCREENING FOR COMMON MENTAL DISORDERS DEPRESSIVE AND ANXIETY DISORDERS SUBSTANCE USE DISORDERS SCREENING FOR COMMON MENTAL DISORDERS DEPRESSIVE AND ANXIETY DISORDERS SUBSTANCE USE DISORDERS COMMON MENTAL DISORDERS Depressive Disorders Anxiety Disorders Substance use disorders CMD in HIV Twice as

More information

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project

Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation. Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project Benzodiazepines: Comparative Effectiveness and Strategies for Discontinuation Ann M. Hamer, PharmD, BCPP Rural Oregon Academic Detailing Project This project is funded through a grant from the Pew Charitable

More information

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE

SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE SHARED CARE GUIDELINE FOR THE MANAGEMENT OF PATIENTS ON NALTREXONE FOR OPIOID DEPENDENCE INDICATION Naltrexone is a pure opiate antagonist licensed as an adjunctive prophylactic therapy in the maintenance

More information

Table of Contents VOLUME 1

Table of Contents VOLUME 1 VOLUME 1 A Accidents and Injuries from Alcohol... 1 Accidents and Injuries from Drugs..... 4 Addiction: Concepts and Definitions... 7 Addictive Personality............... 12 Adolescents, Drug and Alcohol

More information

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES? Psychiatry and Addictions Case Conference UW Medicine Psychiatry and Behavioral Sciences WHEN AND HOW TO USE BENZODIAZEPINES IN TREATING ANXIETY: AM I WITHHOLDING TREATMENT IF I DON'T USE BENZODIAZEPINES?

More information

ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B)

ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B) ADULT Addictions Treatment: Medically Monitored Residential Treatment (3B) Program Medically Monitored Short Term Residential treatment provides 24 hour professionally directed evaluation, care, and treatment

More information

Opioids Research to Practice

Opioids Research to Practice Opioids Research to Practice CRIT Program May 2010 Daniel P. Alford, MD, MPH Associate Professor of Medicine Boston University School of Medicine Boston Medical Center 32 yo female brought in after heroin

More information

Welcome to MedWell. Patient Information. Name: Address: City: State: Zip Code: !Other. Name: Address: City: State:

Welcome to MedWell. Patient Information. Name: Address: City: State: Zip Code:   !Other. Name: Address: City: State: 1 Welcome to MedWell Patient Information Date: Name: Date of Birth: / / Address: City: State: Zip Code: Home Phone: ( ) - Cell Phone: ( ) - Email: Gender:! Male! Female Last 4 of Social Security Number

More information

Medical Necessity Criteria 2017

Medical Necessity Criteria 2017 Medical Necessity Criteria 2017 The New Directions Medical Necessity Criteria have been revised. The new version will be effective January 1, 2017. See https://www.ndbh.com/providers/behavioralhealthplanproviders.aspx.

More information

The National Methamphetamine Symposium

The National Methamphetamine Symposium The National Methamphetamine Symposium Making Research Work in Practice 12 May 2015 Arts Centre, Melbourne Physical and psychological effects of methamphetamine use Amanda Baker PhD National Centre for

More information

Screening and Addressing Alcohol Use In Primary Care

Screening and Addressing Alcohol Use In Primary Care Screening and Addressing Alcohol Use In Primary Care Mark R. Loush, LMSW, CAADC August 15, 20167 Objectives Identify the primary reasons why screening for alcohol in primary care is important Understand

More information

Management of substance use disorders in primary care. Meldon Kahan, MD

Management of substance use disorders in primary care. Meldon Kahan, MD Management of substance use disorders in primary care Meldon Kahan, MD i 2015 Women s College Hospital All rights reserved. Version date: November 27, 2015 ii Contents Introduction... vii Part I: Alcohol

More information

TEMGESIC Injection Buprenorphine (as hydrochloride)

TEMGESIC Injection Buprenorphine (as hydrochloride) TEMGESIC Injection Buprenorphine (as hydrochloride) Consumer Medicine Information What is in this leaflet This leaflet answers some common questions about TEMGESIC. It does not contain all the available

More information

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines)

(Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Buprenorphine Initiation and Maintenance in Pregnancy (Adapted with permission from the D-H Knowledge Map Primary Care Buprenorphine Guidelines) Assessment The diagnosis of OUD should be confirmed by DSM-5

More information

DRAFT FOR CONSULTATION

DRAFT FOR CONSULTATION 1) What is the accuracy of a tool and/or clinical judgement for the a) assessment b) monitoring of patients at risk of acute alcohol withdrawal? 2) Does the assessment and monitoring of patients with acute

More information

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013

Management of high risk MMT patients. Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 Management of high risk MMT patients Meldon Kahan MD Methadone Prescribers Conference Toronto, Nov 15, 2013 CFPC CoI Templates: Slide 1 Faculty Disclosure Faculty: Meldon Kahan Relationships with commercial

More information

ROSC & MAT II: Opioid Treatment Services

ROSC & MAT II: Opioid Treatment Services ROSC & MAT II: Opioid Treatment Services September 23, 2015 Stan DeKemper Executive Director Indiana Credentialing Association on Addiction and Drug Abuse 1 GOALS Review medication assisted recovery Identify

More information

Treatment Approaches for Drug Addiction

Treatment Approaches for Drug Addiction Treatment Approaches for Drug Addiction NOTE: This fact sheet discusses research findings on effective treatment approaches for drug abuse and addiction. If you re seeking treatment, you can call the Substance

More information

Prescribing for substance misuse: alcohol detoxification. Clinical background

Prescribing for substance misuse: alcohol detoxification. Clinical background Prescribing for substance misuse: alcohol detoxification POMH-UK Quality Improvement Programme. Topic 14a: baseline Clinical background 1 2014 The Royal College of Psychiatrists. For further information

More information

The science of the mind: investigating mental health Treating addiction

The science of the mind: investigating mental health Treating addiction The science of the mind: investigating mental health Treating addiction : is a Consultant Addiction Psychiatrist. She works in a drug and alcohol clinic which treats clients from an area of London with

More information

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment

ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment ten questions you might have about tapering (and room for your own) an informational booklet for opioid pain treatment This booklet was created to help you learn about tapering. You probably have lots

More information

Alcohol withdrawal. Clinical features

Alcohol withdrawal. Clinical features Alcohol withdrawal Clinical features Severity increase with amount consumed; uncommon with < drinks per day. Predictable pattern: patients with previous withdrawal seizures are at high risk for recurrence.

More information

What is the worst day of xanax withdrawal

What is the worst day of xanax withdrawal What is the worst day of xanax withdrawal The Borg System is 100 % What is the worst day of xanax withdrawal For most people, benzo withdrawal isn't a matter of days, but months or even years. The withdrawal

More information

Prescribing Framework for Naltrexone in Alcohol Relapse Prevention

Prescribing Framework for Naltrexone in Alcohol Relapse Prevention Prescribing Framework for Naltrexone in Alcohol Relapse Prevention Patients Name:.. NHS Number: Patients Address:... (Use addressograph sticker) GP s Name:... Communication We agree to treat this patient

More information

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept.

THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE. Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. THE MEDICAL MODEL: ADDICTION IS A BRAIN DISEASE Judith Martin, MD Medical Director of Substance Use Services San Francisco Dept. Public Health disclosures Dr. Martin has no conflict of interest to disclose.

More information

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008

Buprenorphine: An Introduction. Sharon Stancliff, MD Harm Reduction Coalition September 2008 Buprenorphine: An Introduction Sharon Stancliff, MD Harm Reduction Coalition September 2008 Objective Participants will be able to: Discuss the role of opioid maintenance in reducing morbidity and mortality

More information

What is the most important information I should know about midazolam?

What is the most important information I should know about midazolam? midazolam (oral) Pronunciation: mye DAZ oh lam Brand: Versed What is the most important information I should know about midazolam? Midazolam can slow or stop your breathing, especially if you have recently

More information

Alcohol. ALCOHOL - BODY and SOUL. Body and Soul

Alcohol. ALCOHOL - BODY and SOUL. Body and Soul Alcohol Body and Soul 1 Contents Alcohol Standard Drinks 1 Continuum of Risk 2 Brain and Nervous System (1) 3 Brain and Nervous System (2) 4 Liver 5 Stomach, Intestines and Pancreas 6 Heart, Lungs and

More information

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS

C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS C AT E G O R Y I I I COMMUNICATION, TREATMENT & PREVENTION INTERVENTIONS PHARMACOLOGY OF ADDICTIONS 1.0 Introduction Medications are used in the treatment of drug, alcohol and nicotine dependence to manage

More information

Benzodiazepine Misuse Abuse - Dependence Using for recreational purposes Continued long term use against medical advise Use of drug with other potenti

Benzodiazepine Misuse Abuse - Dependence Using for recreational purposes Continued long term use against medical advise Use of drug with other potenti Benzodiazepine Prescribing In Primary Care Settings: Issue for Concern? Louis E. Baxter, Sr., M.D., FASAM Executive Medical Director Professional Assistance Program, New Jersey, Inc. Benzodiazepine Misuse

More information

Clinical Evaluation: Assessment Goals

Clinical Evaluation: Assessment Goals Clinical Evaluation: Assessment Goals 1. Define Assessment Process 2. Identify Assessment Instruments 3. Define DSM-5 criteria for Substance Abuse and Dependence, specifiers and multi-axial assessment

More information

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM

An Internist s Guide to Unhealthy Alcohol Use. Ryan Graddy, MD JHU SOM An Internist s Guide to Unhealthy Alcohol Use Ryan Graddy, MD JHU SOM Disclosures None Learning Objectives Understand the terminology used to describe unhealthy alcohol use Identify means of screening

More information

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS

DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS DRUGS USED IN THE TREATMENT OF ADDICTION JOSEPH A. TRONCALE, MD FASAM RETREAT PREMIERE ADDICTION TREATMENT CENTERS MAJOR CATEGORIES OF TREATMENTS Detoxification and Post-Acute Withdrawal Maintenance Co-Occurring

More information

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment

some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment some things you should know about opioids before starting a prescription an informational booklet for opioid pain treatment This booklet was created to help you learn about opioids. You probably have lots

More information

Withdrawal.

Withdrawal. Withdrawal Shamim Nejad, MD Director, Adult Burns & Trauma Psychiatry Division of Psychiatry and Medicine Medical Director, Addiction Consultation Team MGH Center for Addiction Medicine Massachusetts General

More information

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected.

KEY MESSAGES. It is often under-recognised and 30-50% of MDD cases in primary care and medical settings are not detected. KEY MESSAGES Major depressive disorder (MDD) is a significant mental health problem that disrupts a person s mood and affects his psychosocial and occupational functioning. It is often under-recognised

More information

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH

BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH BAPTIST HEALTH SCHOOL OF NURSING NSG 3036A: PSYCHIATRIC-MENTAL HEALTH THERAPEUTIC INTERVENTION AND RESOURCE MANAGEMENT: SUBSTANCE RELATED DISORDERS: CO-DEPENDENCY AND THE IMPAIRED NURSE LECTURE OBJECTIVES:

More information

Models of good practice in drug treatment in Europe. Project group

Models of good practice in drug treatment in Europe. Project group Models of good practice in drug treatment in Europe ( moretreat 2006329 ) Project group Hamburg, London, Rome, Stockholm, Vienna, Warsaw, Zurich Project duration: 17 months from April 2006 August 2008

More information

Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115

Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115 Alcohol-use disorders: diagnosis, assessment and management of harmful drinking and alcohol dependence Clinical guideline Published: 23 February 2011 nice.org.uk/guidance/cg115 NICE 2018. All rights reserved.

More information

Medication Guide. Sertraline Hydrochloride (ser' tra leen hye'' droe klor' ide) Tablets

Medication Guide. Sertraline Hydrochloride (ser' tra leen hye'' droe klor' ide) Tablets Medication Guide Sertraline Hydrochloride (ser' tra leen hye'' droe klor' ide) Tablets What is the most important information I should know about sertraline hydrochloride tablets? Sertraline hydrochloride

More information

A prisoners guide to buprenorphine

A prisoners guide to buprenorphine A prisoners guide to buprenorphine 2 The Opium poppy In the land of far, far away the opium poppy grows. The seed pods of this poppy are scratched until they drip with a sticky resin called opium. Raw

More information

THE STATE OF MEDICINE IN ADDICTION RECOVERY

THE STATE OF MEDICINE IN ADDICTION RECOVERY OVERVIEW: Review addiction stats and trends Define addiction Explain neurobiology of addiction Review treatments of addiction Addiction Definition: A Primary, chronic, relapsing disease of brain reward,

More information

INITIAL PATIENT INTAKE FORM

INITIAL PATIENT INTAKE FORM INITIAL PATIENT INTAKE FORM Name: Last Name First Name Date of Birth: MM / DD / YYYY Gender: Male Female Address: Town: State: Zip Code: Preferred method of contact. For internal promotional use only.

More information

Top of the World Ranch Treatment Centre Admissions Information Record Demographics

Top of the World Ranch Treatment Centre Admissions Information Record Demographics 1 Client Name: Top of the World Ranch Treatment Centre Admissions Information Record Demographics : of Birth: Health Card #: Gender: Male Female Phone #: May we leave a message? Street Address: Email Address:

More information

Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders. Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC

Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders. Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC Shhh! Let s Talk About Moderation for Mild Alcohol Use Disorders Cyndi Turner, LCSW, LSATP, MAC Craig James, LCSW, MAC Shhh! Let s Talk About Moderation for Mild to Moderate Alcohol Use Disorders Insight

More information

Westminster Memory Services Pathways Toolkit (updated October 2016)

Westminster Memory Services Pathways Toolkit (updated October 2016) Westminster Memory Services Pathways Toolkit (updated October 2016) Contents Aims... 2 Memory loss experienced by service users... 2 Signs of memory loss... 2 Alcohol dependency and memory loss... 3 Other

More information

SMOKING CESSATION IS HARD

SMOKING CESSATION IS HARD POWER TO BREAK THE HOLD OF NICOTINE ADDICTION 1 SMOKING CESSATION IS HARD Most smokers try to quit 5-7 times before they are successful. 2 Why is it so hard to quit? Typical withdrawal symptoms from stopping

More information

A new model for prescribing varenicline

A new model for prescribing varenicline Pharmacist Independent Prescribers in partnership with A new model for prescribing varenicline Dear Stop Smoking Advisor You will be aware of the stop smoking drug varenicline that goes under the brand

More information

MO DRI-2 Instructions We realize this is a difficult time for you. Nevertheless, we need more information so we can better understand your situation.

MO DRI-2 Instructions We realize this is a difficult time for you. Nevertheless, we need more information so we can better understand your situation. MO DRI-2 Instructions We realize this is a difficult time for you. Nevertheless, we need more information so we can better understand your situation. All questions in this questionnaire should be answered.

More information

Smoking Cessation Pharmacotherapy Guidelines

Smoking Cessation Pharmacotherapy Guidelines Smoking Cessation Pharmacotherapy Guidelines INTRODUCTION This guideline is based on public health guidance 10 Smoking Cessation Services issued by the National Institute for Health and Clinical Excellence

More information